Nuveen Asset Management LLC Boosts Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Nuveen Asset Management LLC increased its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 34.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 422,475 shares of the company's stock after purchasing an additional 107,695 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.11% of LifeStance Health Group worth $3,114,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LFST. Blue Trust Inc. lifted its position in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after buying an additional 2,122 shares during the last quarter. LPL Financial LLC raised its stake in LifeStance Health Group by 6.0% during the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company's stock worth $277,000 after acquiring an additional 2,127 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in LifeStance Health Group by 2.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after acquiring an additional 3,305 shares in the last quarter. MetLife Investment Management LLC lifted its position in LifeStance Health Group by 6.8% in the fourth quarter. MetLife Investment Management LLC now owns 85,914 shares of the company's stock valued at $633,000 after acquiring an additional 5,492 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in LifeStance Health Group by 4.6% in the fourth quarter. Legal & General Group Plc now owns 134,557 shares of the company's stock valued at $992,000 after acquiring an additional 5,917 shares in the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares of the company's stock, valued at approximately $2,344,689. The trade was a 5.25% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 3.20% of the stock is owned by insiders.

LifeStance Health Group Stock Performance

Shares of NASDAQ:LFST traded up $0.08 on Tuesday, reaching $5.96. The company's stock had a trading volume of 1,863,509 shares, compared to its average volume of 1,593,707. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $8.61. The stock has a market capitalization of $2.32 billion, a P/E ratio of -22.92 and a beta of 1.30. The stock's 50-day moving average is $6.31 and its two-hundred day moving average is $7.11. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32.

Analyst Ratings Changes

A number of analysts have recently commented on LFST shares. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target on the stock. KeyCorp began coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target on the stock. Finally, UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price objective for the company in a report on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $8.50.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.